CY1802A - Agents for lowering the blood pressure - Google Patents

Agents for lowering the blood pressure

Info

Publication number
CY1802A
CY1802A CY180295A CY180295A CY1802A CY 1802 A CY1802 A CY 1802A CY 180295 A CY180295 A CY 180295A CY 180295 A CY180295 A CY 180295A CY 1802 A CY1802 A CY 1802A
Authority
CY
Cyprus
Prior art keywords
lowering
agents
blood pressure
blood
pressure
Prior art date
Application number
CY180295A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1802(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CY1802A publication Critical patent/CY1802A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY180295A 1988-03-23 1995-02-17 Agents for lowering the blood pressure CY1802A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17274788A 1988-03-23 1988-03-23

Publications (1)

Publication Number Publication Date
CY1802A true CY1802A (en) 1995-02-17

Family

ID=22629045

Family Applications (1)

Application Number Title Priority Date Filing Date
CY180295A CY1802A (en) 1988-03-23 1995-02-17 Agents for lowering the blood pressure

Country Status (19)

Country Link
EP (1) EP0334429B1 (pt)
JP (1) JPH0637487B2 (pt)
KR (1) KR970011287B1 (pt)
AU (1) AU621591B2 (pt)
CA (1) CA1337432C (pt)
CY (1) CY1802A (pt)
DE (2) DE19675037I1 (pt)
DK (1) DK174422B1 (pt)
ES (1) ES2052881T3 (pt)
GR (1) GR3006972T3 (pt)
HK (1) HK123594A (pt)
HU (1) HU211539A9 (pt)
IE (1) IE62159B1 (pt)
IL (1) IL89691A (pt)
LU (1) LU88842I2 (pt)
NL (1) NL950031I2 (pt)
NZ (1) NZ228321A (pt)
PT (1) PT90095B (pt)
ZA (1) ZA892179B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
EP0801564B1 (en) * 1994-12-28 2002-03-27 Janssen Pharmaceutica N.V. Use of nebivolol as an anti-atherogenic
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5663194A (en) * 1995-07-25 1997-09-02 Mewshaw; Richard E. Chroman-2-ylmethylamino derivatives
US5684039A (en) * 1995-07-25 1997-11-04 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5670667A (en) * 1995-07-25 1997-09-23 American Home Products Corporation Chroman-2-ylmethylamino derivatives
PT1121111E (pt) 1998-10-15 2010-05-17 Imp Innovations Ltd Compostos para o tratamento de perda de peso
JP2004528337A (ja) 2001-05-02 2004-09-16 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化ネビボロール、ならびにその代謝産物、組成物、および使用方法
EP1737847B1 (en) 2004-07-30 2008-06-04 Torrent Pharmaceuticals Ltd Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
EP1776354B1 (en) * 2004-08-11 2010-04-21 Hetero Drugs Limited A novel process for preparation of nebivolol intermediates
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
JP2008528627A (ja) * 2005-01-31 2008-07-31 マイラン ラボラトリーズ インク． グルクロン酸化されたネビボロール代謝産物
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
CN100546987C (zh) * 2005-03-03 2009-10-07 浙江医药股份有限公司新昌制药厂 Dl-奈必洛尔及其盐酸盐的制备方法
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1973895A1 (en) 2006-01-18 2008-10-01 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
JP5281012B2 (ja) * 2006-11-27 2013-09-04 ザック システム エス．ピー．エー． ネビボロールの調製方法
CN103087028B (zh) * 2006-11-27 2014-12-24 Zach系统股份公司 制备奈必洛尔的方法
GB0624282D0 (en) 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
US20100137424A1 (en) 2007-01-22 2010-06-03 Mostafa Akbarieh Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
CN101531651B (zh) * 2008-03-13 2011-05-04 四川大学 光学活性3,4-二氢-2h-1-苯并吡喃-2-羧酸和3,4-二氢-4-氧-2h-1-苯并吡喃-2-羧酸类化合物的制备方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) * 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
US8785664B2 (en) 2010-02-11 2014-07-22 Menarini International Operations Luxembourg S.A. Process for the preparation of nebivolol
IT1402974B1 (it) * 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
WO2014111903A2 (en) 2013-01-21 2014-07-24 Cadila Pharmaceuticals Limited A process for the preparation of 6-fluoro-3,4-dihydro-2h-chromene- 2-carbaldehyde
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
EP2907809B1 (en) 2014-02-14 2018-08-22 Corden Pharma International GmbH Base-free process for the preparation of ketone intermediates usable for manufacture of nebivolol
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
JP6847095B2 (ja) 2015-05-19 2021-03-24 チョーチアン オウスン ファーマシューティカル カンパニー リミテッド ネビボロールの合成方法及びその中間化合物
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
ITUB20160227A1 (it) 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol

Also Published As

Publication number Publication date
DK146289A (da) 1989-09-24
JPH0637487B2 (ja) 1994-05-18
EP0334429A1 (en) 1989-09-27
LU88842I2 (fr) 1997-01-27
PT90095B (pt) 1994-11-30
NL950031I2 (nl) 1997-01-06
ES2052881T3 (es) 1994-07-16
DK174422B1 (da) 2003-02-24
AU621591B2 (en) 1992-03-19
KR890014510A (ko) 1989-10-24
NL950031I1 (pt) 1996-02-01
DE68903516T2 (de) 1993-04-01
HK123594A (en) 1994-11-18
IE890906L (en) 1989-09-23
CA1337432C (en) 1995-10-24
GR3006972T3 (pt) 1993-06-30
HU211539A9 (en) 1995-12-28
KR970011287B1 (ko) 1997-07-09
DK146289D0 (da) 1989-03-22
IL89691A (en) 1994-04-12
NZ228321A (en) 1991-02-26
DE68903516D1 (de) 1992-12-24
DE68903516C5 (de) 2017-07-13
JPH01283220A (ja) 1989-11-14
AU3074289A (en) 1989-09-28
IE62159B1 (en) 1994-12-28
EP0334429B1 (en) 1992-11-19
IL89691A0 (en) 1989-09-28
DE19675037I1 (de) 2003-09-04
PT90095A (pt) 1989-11-10
ZA892179B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
HK123594A (en) Agents for lowering the blood pressure
GB8928826D0 (en) Lowering unit area pressure
IL93715A0 (en) Pressure monitor catheter
EP0350675A3 (en) Blood reservoir
GB8805961D0 (en) Pressure controller
EP0377749A4 (en) Catheter
EP0301273A3 (en) Fluid compressor
GB8820185D0 (en) New medical use
EP0377674A4 (en) Fluid barrier for medical dressing
GB2234915B (en) Ambulatory wheelstand
AU112713S (en) Blood pressure monitor
GB8903292D0 (en) Fluid treatment
GB8726263D0 (en) Fluid displacement
EP0376912A3 (en) Fluid bed processes
GR910300099T1 (en) Sphygmomanometer
SG118694G (en) Agents for lowering the blood pressure
GB2233551B (en) Pressure controller
GB2222962B (en) Fluid administration set
GB8724739D0 (en) Lowering unit area pressure
GB8826007D0 (en) Lowering unit area pressure
GB8811797D0 (en) Medical electropromt
GB8625205D0 (en) Lowering unit area pressure
GB8810308D0 (en) Fluid beds
GB8805944D0 (en) Pressure contrast structures
GB8707449D0 (en) Pressure contrast structures